CBD-OS

DRUG2 trials

Sponsors

Jazz Pharmaceuticals

Conditions

Developmental and Epileptic Encephalopathy (DEE)Focal Seizures

Phase 1

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

RecruitingNCT07233239

Jazz PharmaceuticalsFocal Seizures

Start: 2025-11-26End: 2027-11-29Target: 100Updated: 2026-08-11

Phase 3

A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE

Not yet recruitingNCT07723976

Jazz PharmaceuticalsDevelopmental and Epileptic Encephalopathy (DEE)

Start: 2026-10-30End: 2029-09-04Target: 120Updated: 2026-07-24